Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-07-07

Clinical Trial Update: A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy [NA]

View source ↗

Summary

A randomized study compares lamivudine versus adefovir dipivoxil to prevent hepatitis B reactivation in HBsAg-positive patients undergoing cytotoxic chemotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adefovir Dipivoxil (Adefovir dipivoxil)
  • Lamivudine (lamivudine)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Hepatitis B | NA | Status: UNKNOWN